PBX3 and colorectal carcinoma: First, PBL PBX3 hypermethylation was significantly associated with a better OS and obviously correlated with a longer OS time in a collection of 144 stage III CRC patients or in 129 patients with colon cancer, while this was independent of other core clinical variables.